Teva loses plea against GSK’s $235m ‘skinny label’ win
16-05-2023
GSK signs licence deals with three generics firms to make HIV preventative for low income countries
30-03-2023
SCOTUS invites govt comment on Teva clash
04-10-2022
Generic maker urges review of $235m skinny label decision
08-09-2022
GSK bets $2.1bn on Boston-based biopharma company
01-06-2022
Swiss scientist convicted for GSK trade secrets theft
03-05-2022